Skip to content
Peptigraph home

MOTS-c

Mitochondrial-derived peptide. MOTS-c is not FDA approved for any use.

Also called:mots
Medically reviewed by Juan Pablo Frías, MD · · DisclosureUpdated Strongest evidence: Human RCT evidence, 4 of 4
StatusPCAC voted 7–5 for 503A (Jul 2026)Removed from FDA Category 2 on 15 Apr 2026. PCAC voted 7–5 for the 503A list (Jul 2026); not finalized.Prohibited by WADA (S4.4.1)Full legal history

Key facts

Class
Mitochondrial-derived peptide
Also called
mots
Vial sizes sold
5 mg, 10 mg, 20 mg, 40 mg
Community-reported sizes
Half-life
Not found
No published half-life found (PubMed search, 11 Oct 2026)
FDA status
Not approved
Off Category 2, 15 Apr 2026
PCAC vote
7–5 for 503A
Jul 2026, not final
WADA
Prohibited (S4.4.1)
In and out of competition
Everything on MOTS-c

MOTS-c guides

Vial and dose sizes

Evidence at a glance

Human and animal counts are PubMed records from our evidence ledger (search counts, not studies we reviewed). The grade is the strongest design among the studies we summarised for that goal: a human randomized trial outweighs any number of animal studies.

MOTS-c: studies by condition
ConditionHuman studiesAnimal studiesStudies we summarisedEvidence grade
Energy653Human RCT evidence, 4 of 4Scientific reports 2021, PMID 34413391
Weight loss12134Human RCT evidence, 4 of 4Scientific reports 2021, PMID 34413391
Muscle growth624Human RCT evidence, 4 of 4Medicine and science in sports and exercise 2025, PMID 40674654
Diabetes25165Human RCT evidence, 4 of 4Aging 2022, PMID 36490309
Bone health222Animal evidence, 2 of 4Biochemical and biophysical research communications 2016, PMID 27237975
Menopause102Animal evidence, 2 of 4Journal of molecular medicine 2019, PMID 30725119
FertilityNot in our ledgerNot in our ledger0No graded study for this goal
LiverNot in our ledgerNot in our ledger0No graded study for this goal
MetabolismNot in our ledgerNot in our ledger0No graded study for this goal
SleepNot in our ledgerNot in our ledger0No graded study for this goal
TestosteroneNot in our ledgerNot in our ledger0No graded study for this goal

Grades follow our evidence scale. Summarised studies come from our evidence file, each quote checked against the abstract or label.

MOTS-c: a peptide encoded by mitochondrial DNA

MOTS-c is encoded in mitochondrial DNA. In mice aged 2, 12 and 22 months it enhanced physical performance.[19]

In the original mouse study, MOTS-c prevented diet-induced obesity and insulin resistance. This is mouse data only.[20]

What people studies do and do not show

In one trial of breast cancer survivors, a 16-week aerobic and resistance programme raised the body's own MOTS-c levels in non-Hispanic White participants. This measures natural levels, not an injected peptide.[6]

A study of people with and without obesity found no significant difference in serum MOTS-c.[21]

In breast cancer patients, circulating MOTS-c did not change significantly over a 24-week chemotherapy regimen with or without metformin.[8]

Regulatory path

FDA lists no approved MOTS-c product.[4]

MOTS-c was removed from FDA's 503A category 2 after the nominator withdrew; FDA announced a PCAC consultation on 23 July 2026.[5]

WADA names MOTS-c among the AMPK activators in S4.4.1, prohibited at all times.[3]

FDA's safety-risk entry for MOTS-c notes that the agency found no human exposure data on MOTS-c drug products for any route of administration.[22]

Compared with

Common stacks

MOTS-c is often sold pre-mixed or combined with other peptides. No controlled study has tested these combinations; the pages below cover the math and what each part has been studied for.

Common questions

Is MOTS-c FDA approved?

No. MOTS-c is not FDA approved for any use. The FDA removed it from Category 2 on 15 Apr 2026. Its advisory committee voted 7–5 in July 2026 to add it to the 503A compounding list. That vote is not final.

Is MOTS-c banned in sport?

Yes. Prohibited by WADA (S4.4.1), so it is prohibited at all times for tested athletes.

How much water goes in a 10 mg vial?

That choice only changes the concentration. With 2 mL, the vial is 5 mg/mL. The calculator converts any amount to syringe units. It does the math only and does not suggest a dose.

What is MOTS-c?

A short peptide encoded in mitochondrial DNA, studied so far mainly in mice and cells.[19]

What does MOTS-c do?

In mice it prevented diet-induced obesity and insulin resistance; human injection trials were not found.[20]

How does MOTS-c work?

In a cell-culture study of bone cells, it promoted collagen synthesis through TGF-beta/SMAD signalling.[23]

Sources

  1. 1Certain bulk drug substances for use in compounding that may present significant safety risks (Category 2; 'nominated but withdrawn' table, content current as of 22 Apr 2026)U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
  2. 2Pharmacy Compounding Advisory Committee meeting, 23–24 Jul 2026 (agenda and materials)U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
  3. 3World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
  4. 4United States: No FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "MOTS-c" returned no matches on 2 Oct 2026.U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
  5. 5US compounding: MOTS-c was removed from FDA's 503A category 2 after the nominator withdrew; FDA announced a PCAC consultation on 23 July 2026.U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
  6. 6Effect of aerobic and resistance exercise on the mitochondrial peptide MOTS-c in Hispanic and Non-Hispanic White breast cancer survivors.Scientific reports · 2021PMID 34413391Accessed 2 Oct 2026
  7. 7Repeated Heat Stress Modulates the Levels of the Mitokines MOTS-C and FGF21 in Active Men during Calf Muscle Immobilization.Medicine and science in sports and exercise · 2025PMID 40674654Accessed 2 Oct 2026
  8. 8Circulating levels of MOTS-c in patients with breast cancer treated with metformin.Aging · 2022PMID 36490309Accessed 2 Oct 2026
  9. 9PubMed search: ("MOTS-c"[tiab] OR MOTSc[tiab]) (262 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  10. 10PubMed search: ("MOTS-c"[tiab] OR MOTSc[tiab]) AND (humans[mh] OR human[tiab] OR participants[tiab] OR patients[tiab] OR volunteers[tiab]) (179 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  11. 11PubMed search: ("MOTS-c"[tiab] OR MOTSc[tiab]) AND (randomized controlled trial[pt] OR "clinical trial"[pt] OR "meta-analysis"[pt] OR "systematic review"[pt]) (5 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  12. 12PubMed search: ("MOTS-c"[tiab] OR MOTSc[tiab]) AND (mice[tiab] OR mouse[tiab] OR rat[tiab] OR rats[tiab]) AND (injection[tiab] OR treatment[tiab] OR administration[tiab] OR treated[tiab]) (72 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  13. 13PubMed search: ("MOTS-c"[tiab] OR MOTSc[tiab]) AND (half-life[tiab] OR pharmacokinetic*[tiab]) (3 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  14. 14Advisory committee backs 6 of 7 peptides for the 503A listNCPA · 2026ncpa.org
  15. 15FDA gives notice that 12 peptides will be removed from Category 2 (nominations withdrawn)FDA · 2026fda.govAccessed 2 Oct 2026
  16. 16Mitochondria related peptide MOTS-c suppresses ovariectomy-induced bone loss via AMPK activation.Biochemical and biophysical research communications · 2016PMID 27237975Accessed 2 Oct 2026
  17. 17MOTS-c peptide regulates adipose homeostasis to prevent ovariectomy-induced metabolic dysfunction.Journal of molecular medicine (Berlin, Germany) · 2019PMID 30725119Accessed 2 Oct 2026
  18. 18PubMed search: ("MOTS-c"[tiab] OR MOTSc[tiab] OR CB4211[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (20 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
  19. 19MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis.Nature communications · 2021PMID 33473109Accessed 2 Oct 2026
  20. 20The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.Cell metabolism · 2015PMID 25738459Accessed 2 Oct 2026
  21. 21MOTS-C levels ın ındividuals with and without obesity and ıts association with ınflammation, insulin resistance and endothelial dysfunction.Archives of endocrinology and metabolism · 2025PMID 41004666Accessed 2 Oct 2026
  22. 22Official web pageOfficial web page · web page
  23. 23MOTS-c improves osteoporosis by promoting the synthesis of type I collagen in osteoblasts via TGF-β/SMAD signaling pathway.European review for medical and pharmacological sciences · 2019PMID 31081069Accessed 2 Oct 2026

Found an error? Report a correction.